The event brought together 50 MPs, peers, government representatives, researchers, patients and supporters to discuss how the UK can accelerate progress in pancreatic cancer treatment and improve outcomes for patients.
Alongside showcasing Pancreatic Cancer UK-funded research taking place at Oxford, the reception focused on the charity’s call for pancreatic cancer to remain a priority within the Government’s National Cancer Plan. Key messages included improving access to personalised treatment through tumour testing, expanding access to clinical trials by ensuring eligible patients are linked to available studies, and increasing investment in pancreatic cancer research and treatment development.
Mr Jones attended the event with his co-principal investigator, Dr Michael Gray of the Institute of Biomedical Engineering (IBME). Together, they lead a Pancreatic Cancer UK-funded project investigating whether high-intensity focused ultrasound (HIFU) can stimulate the immune system to target pancreatic cancer.
Read the full story on the Nuffield Department of Surgical Sciences website.